NAVSUNLI Trademark

Trademark Overview


On Friday, November 1, 2024, a trademark application was filed for NAVSUNLI with the United States Patent and Trademark Office. The USPTO has given the NAVSUNLI trademark a serial number of 98833538. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 6, 2026. This trademark is owned by REGENXBIO Inc.. The NAVSUNLI trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for...
navsunli

General Information


Serial Number98833538
Word MarkNAVSUNLI
Filing DateFriday, November 1, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, April 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 3, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBiological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, lysosomal enzyme expression
Description of MarkThe mark consists of a half sun with two lines extending outward and the word "NAVSUNLI" written below.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREGENXBIO RS LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressROCKVILLE, MD 20850
US

Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, DE 20850
US

Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, DE 20850
US

Trademark Events


Event DateEvent Description
Friday, November 1, 2024NEW APPLICATION ENTERED
Thursday, December 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 30, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 1, 2025ASSIGNED TO EXAMINER
Tuesday, May 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 3, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 6, 2026SOU TEAS EXTENSION RECEIVED
Monday, April 6, 2026SOU EXTENSION 1 FILED
Monday, April 6, 2026SOU EXTENSION 1 GRANTED
Tuesday, April 7, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED